The hair-restoration market (including oral medications, laser treatments, and hair-growth shampoos) reached a staggering $8.77 billion globally in 2023, according to market research company Grand View Research
Novo Nordisk dominates the GLP-1 market for now Novo Nordisk dominates the GLP-1 market for now Since 2005, there have been 8 different non-insulin combined formulations of GLP-1 receptor agonists ( Table 1 )
In addition, they have positive impact on several cardiovascular risk factors such as obesity by promoting weight loss, blood pressure and blood lipid levels
doi: 10.3390/ijms232314631, Summary Keywords GLP-1/GIP dual agonist, metabolic regulation, obesity, obstructive sleep apnea, tirzepatide Citation Fang Q, Zhu Y, Rao M and Liu P (2026) GLP-1/GIP dual agonist tirzepatide in obstructive sleep apnea syndrome: mechanisms, evidence, and clinical perspectives
A meta-analysis published in April 2022 found that massage relieved the severity of symptoms without increasing the risk of adverse events
oral tirzepatide dissolving tablets sell as a three-month supply at $1,047 ($891 paid in full) with no month-to-month rate and no injectable tirzepatide offered as of July 2026